To me the only explanation for our languishing share price is that the market doesn't believe the deal will go through. If it does (and all rhetoric from the company thus far suggests it will) we become a growth company again on the back of LifX alone. 38.5 million in revenue, growing at 70-100% each year. Even if they grow at 30% this year, that's 50 million. Combined market cap post deal at 9.5c is c. 168 million and we're at 5.8c now. Risk reward seems to be back in our favour. Fingers crossed that it all works out.
BUD Price at posting:
5.9¢ Sentiment: Buy Disclosure: Held
